DIAMOND HILL CAPITAL MANAGEMENT INC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIAMOND HILL CAPITAL MANAGEMENT INC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,020
-19.7%
28,5740.0%0.00%0.0%
Q2 2023$276,596
-11.7%
28,5740.0%0.00%0.0%
Q1 2023$313,171
+153.7%
28,5740.0%0.00%0.0%
Q4 2022$123,440
-42.6%
28,5740.0%0.00%0.0%
Q3 2022$215,000
-25.1%
28,5740.0%0.00%0.0%
Q2 2022$287,000
-18.9%
28,5740.0%0.00%0.0%
Q1 2022$354,000
-19.4%
28,574
+48.9%
0.00%
-50.0%
Q4 2021$439,000
+7.3%
19,184
+3.9%
0.00%0.0%
Q3 2021$409,000
+71.1%
18,4690.0%0.00%
+100.0%
Q2 2021$239,00018,4690.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders